Depending on how a person administers insulin, different Medicare parts can help cover the costs. For Basaglar, Medicare Part D covers the costs. Medicare Part D, also known as a prescription drug ...

Basaglar will also undercut Sanofi’s longer ... The new pricing scheme is necessary as the cost of insulin has risen sharply for many patients in the last few years. Lilly says this is because ...

The FDA has granted tentative approval for Basaglar (insulin glargine injection), produced by Eli Lilly and Boehringer Ingelheim's (BI) diabetes alliance, following litigation filed by Sanofi ...

oGrowing insulin demand in rural and underserved regions, expanding market penetration. Get Your Free Sample Market Report: What Are the Future Growth Projections for the Basaglar Market?